Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Researchers are continuing to investigate its potential role in cellular repair and genomic stability
Successful treatment of a guanidinoacetate methyltransferase deficient patient: findings with relevance to treatment strategy and pathophysiology
Expecting overnight results Pineal peptides are not sleeping pills
BPC-157 was placed in Category 2 ("may present significant safety risks") in 2023, removed from that category in April 2026, and is now set for a Pharmacy Compounding Advisory Committee review in late July 2026, while CJC-1295 and Ipamorelin were placed in Category 2 back in October 2023
Their scalable nature and compatibility with advanced analytical techniques make peptides valuable across both foundational studies and ongoing research development, supporting consistent, reproducible outcomes in controlled scientific environments
BPC-157 (Body Protection Compound-157) is a synthetic 15 amino acid pentadecapeptide derived from a partial sequence of a protein found in human gastric juice
